NEW ORLEANS, June 29, 2017 -- ClaimsFiler, a FREE shareholder information service, reminds investors that they have only until June 30, 2017 to file lead plaintiff applications in a securities class action lawsuit against Synchronoss Technologies, Inc. (NASDAQ:SNCR). Investor losses must relate to purchases of the Company’s securities between the expanded class period of October 28, 2015 and April 27, 2017. This action is pending in the United States District Court for the District of New Jersey.
Get Help
Synchronoss investors should visit us at https://www.claimsfiler.com/cases/view-synchronoss-technologies-inc-securities-litigation-1 or call to speak to our claim center toll-free at (844) 367-9658.
About ClaimsFiler
ClaimsFiler has a single mission: to serve as the information source to help retail investors recover their share of billions of dollars from securities class action settlements. ClaimsFiler's team of experts monitor the securities class action landscape and cull information from a variety of sources to ensure comprehensive coverage across a broad range of financial instruments.
To learn more about ClaimsFiler, visit www.claimsfiler.com.


SpaceX IPO: Retail Investors to Play Historic Role in Record-Breaking Public Offering
Microsoft Eyes $7B Texas Energy Deal to Power AI Data Centers
Microsoft's $10 Billion Japan Investment: AI Infrastructure and Data Sovereignty Push
Tesla Q1 2026 Deliveries Miss Estimates as AI Strategy Takes Center Stage
Fonterra Admits Anchor Butter "Grass-Fed" Label Misled Consumers After Greenpeace Lawsuit
Norma Group Posts Revenue Decline in 2025, Eyes Modest Recovery in 2026
UAE's Largest Natural Gas Facility Suspended After Attack-Triggered Fire
Apple's Foldable iPhone Faces Engineering Setbacks, Mass Production Timeline at Risk
First Western Ship Transits Strait of Hormuz Since Iran War Began
Paramount Skydance Secures $24B from Gulf Sovereign Wealth Funds for Warner Bros. Discovery Takeover
Samsung Electronics Eyes Record Q1 Profit Amid AI-Driven Chip Boom
RBC Capital: European Medtech Firms Show Minimal Middle East and Energy Risk Exposure
Britain Courts Anthropic Amid US Defense Department Dispute
MATCH Act Targets ASML and Chinese Chipmakers in New U.S. Export Crackdown
OpenAI Executive Shake-Up Ahead of Anticipated 2026 IPO 



